Page last updated: 2024-09-04

pomalidomide and Astrocytoma, Grade IV

pomalidomide has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Liu, H; Luo, Z; Shi, L; Wang, B	1

Other Studies

1 other study(ies) available for pomalidomide and Astrocytoma, Grade IV

Article	Year
TNF Inhibitor Pomalidomide Sensitizes Glioblastoma Cells to EGFR Inhibition. Annals of clinical and laboratory science, 2020, Volume: 50, Issue:4 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; China; ErbB Receptors; Female; Glioblastoma; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Protein Kinase Inhibitors; Signal Transduction; Thalidomide; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha	2020

Article

Year

TNF Inhibitor Pomalidomide Sensitizes Glioblastoma Cells to EGFR Inhibition.

Annals of clinical and laboratory science, 2020, Volume: 50, Issue:4

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; China; ErbB Receptors; Female; Glioblastoma; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Protein Kinase Inhibitors; Signal Transduction; Thalidomide; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha

2020